Effect of ABO blood group on postoperative overall survival and recurrence-free survival rate in patients with hepatocellular carcinoma after hepatectomy: a multi-center retrospective cohort study

• Published in: BMC surgery Vol. 23; no. 1; pp. 1 - 324
• Main Authors: Bahardoust, Mansour, Dehkharghani, Maryam Zolfaghari, Ebrahimi, Pouya, Najafirashed, Maryam, Mousavi, Safa, Haghmoradi, Meisam, Khaleghian, Mohsen, Tizmaghz, Adnan
• Format: Journal Article
• Language: English
• Published: London BioMed Central Ltd 24.10.2023; BioMed Central; BMC
• Subjects: ABO blood group; ABO system; Analysis; Blood groups; Body mass index; Care and treatment; Cohort analysis; Diseases; Glycoproteins; Health care facilities; Hepatectomy; Hepatitis; Hepatocellular carcinoma; Hepatoma; Liver cancer; Lymph nodes; Lymphatic system; Malignancy; Medical centers; Medical science; Metastases; Metastasis; Multivariate analysis; Operating systems; Overall survival rate; Patient outcomes; Patients; Postoperative period; Recurrence-free survival; Relapse; Surgery; Survival; Tumors; α-Fetoprotein; Iran
• ISSN: 1471-2482; 1471-2482
• DOI: 10.1186/s12893-023-02236-8

Abstract Background Hepatocellular carcinoma (HCC) is one of the most common malignancies worldwide. The survival rate after hepatectomy as the first line of treatment for HCC depends on various factors. This study evaluated the association of the ABO blood group and Rh with overall survival (OS) and Recurrence-free survival (RFS) rate after hepatectomy. Methods This multicenter retrospective cohort study reviewed the medical files of 639 HCC patients who underwent hepatectomy from 2010 to 2022 in three medical centers affiliated with the Iran University of Medical Sciences. Patient data, including demographic, clinical, tumor characteristics, and post-surgery outcomes, were collected by referring to the patient’s medical profiles. The Cox proportional hazard investigated the relationship between ABO blood group type and OS and RFS rate after hepatectomy. Results The five-year OS and RFS rates were 25.4% and 18.7%, respectively. The five-year OS (Lok rank:40.89, P:0.001) and RFS rate in patients with blood type A were significantly lower than in non-A patients. (Lok rank:10.8, P:0.001) The multivariate Cox analysis showed that blood type A, age < 45 years, tumor size > 5 cm, Poor tumor differentiation, presence of metastasis, The number of involved lymph nodes ≤ 2, and serum Alpha-Fetoprotein)AFP( level ≥ 400 were significantly related to the decreased survival rate of HCC patients after hepatectomy ( P  < 0.05) There was no significant association between Rh with OS and RFS ( P  > 0.05). Conclusion Blood group type A, compared to non-A, can be associated with decreased OS and RFS rates in patients with HCC after hepatectomy.